Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study

Summary

This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosum. The study finds that senolytic treatment induces oligodendrocyte dysfunction and demyelination, raising concerns about potential adverse effects of anti-aging therapies that target senescent cells. The research highlights that while aging is a risk factor for multiple sclerosis progression, treatments aimed at reducing molecular aging like senolytics may have unintended consequences on myelin-producing cells in the brain.